China Deep Research (14)
14 papers in the China Deep topic, indexed by PF-Atlas from PubMed and global journals.
- Global landscape for pulmonary fibrosis treatment: a data-driven perspective from clinical trials. · BMC pulmonary medicine · 2026
- Current clinical practice including treatment patterns and pathways in idiopathic pulmonary fibrosis patients in China: A real-world analysis · Pharmacoeconomics and Policy · 2026
- C103-12 Targeted Literature Review of Idiopathic Pulmonary Fibrosis Epidemiology and Antifibrotic Treatment Discontinuation · American Journal of Respiratory and Critical Care Medicine · 2026
- [Evidence map analysis of clinical research on treatment of pulmonary fibrosis with proprietary Chinese medicines]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2025
- Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis in China: a sequential exploratory mixed methods research protocol · BMJ Open · 2025
- Harnessing Artificial Intelligence for Accurate Diagnosis and Radiomics Analysis of Combined Pulmonary Fibrosis and Emphysema: Insights from a Multicenter Cohort Study · Semantic Scholar · 2025
- The Presence of Emphysema in Patients with Idiopathic Pulmonary Fibrosis and Lung Cancer: Impact on Tumor Features, Acute Exacerbation, and Survival · Journal of Clinical Medicine · 2025
- [Evidence mapping of clinical research on traditional Chinese medicine in treatment of idiopathic pulmonary fibrosis]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2024
- Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway. · Journal of ethnopharmacology · 2024
- The tolerability and efficacy of antifibrotic therapy in patients with idiopathic pulmonary fibrosis: Results from a real-world study. · Pulmonary pharmacology & therapeutics · 2024
- Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms. · Journal of ethnopharmacology · 2023
- Efficacy of N-acetylcysteine plus pirfenidone in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis · BMC Pulmonary Medicine · 2023
- Clinical efficacy of Chinese herbs for supplementing qi and activating blood circulation combined with N-acetylcysteine in the treatment of idiopathic pulmonary fibrosis: A systematic review and network meta-analysis · PLoS ONE · 2022
- The efficacy and safety of pirfenidone in the treatment of HPS-related pulmonary fibrosis and Idiopathic pulmonary fibrosis: a systematic review and meta-analysis. · European review for medical and pharmacological sciences · 2022
Medical disclaimer. Research listings are for information only and are not medical advice.